NLD-22

N/A

Report date: 2022/01/10 18:08:25
NME

Base Information

Drug NameNLD-22
Drug Alias NameNLD-22
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsHand, Foot and Mouth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNankai University
China Registration ClassN/A

Develop Information

Active CompaniesNankai University
Inactive CompaniesN/A
Active IndicationsHand, Foot and Mouth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A